Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range
Clinical trial NCT05564117 · COMPLETED
Trial details
- NCT number
- NCT05564117
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-11
- Primary completion
- 2024-04-18
- Enrollment
- 307
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.